171 related articles for article (PubMed ID: 2071684)
21. The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon.
Wise RA; Wigley F; Newball HH; Stevens MB
Chest; 1982 Jun; 81(6):695-8. PubMed ID: 7075304
[TBL] [Abstract][Full Text] [Related]
22. Pathophysiological classification of Raynaud's phenomenon.
Nilsen KH
Br J Dermatol; 1980 Jan; 102(1):1-5. PubMed ID: 7378276
[TBL] [Abstract][Full Text] [Related]
23. Standstill of nailfold capillary blood flow during cooling in scleroderma and Raynaud's syndrome.
Maricq HR; Downey JA; LeRoy EC
Blood Vessels; 1976; 13(6):338-49. PubMed ID: 1016736
[TBL] [Abstract][Full Text] [Related]
24. Improving outcome prediction of systemic sclerosis from isolated Raynaud's phenomenon: role of autoantibodies and nail-fold capillaroscopy.
Ingegnoli F; Boracchi P; Gualtierotti R; Biganzoli EM; Zeni S; Lubatti C; Fantini F
Rheumatology (Oxford); 2010 Apr; 49(4):797-805. PubMed ID: 20100796
[TBL] [Abstract][Full Text] [Related]
25. Raynaud's phenomenon and scleroderma.
Harper FE; LeRoy EC
Compr Ther; 1981 Feb; 7(2):45-51. PubMed ID: 6163587
[No Abstract] [Full Text] [Related]
26. Reproducibility of cold provocation in patients with Raynaud's phenomenon.
Wigley FM; Malamet R; Wise RA
J Rheumatol; 1987 Aug; 14(4):751-5. PubMed ID: 3668980
[TBL] [Abstract][Full Text] [Related]
27. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis.
Lekakis J; Mavrikakis M; Emmanuel M; Prassopoulos V; Papazoglou S; Papamichael C; Moulopoulou D; Kostamis P; Stamatelopoulos S; Moulopoulos S
Clin Exp Rheumatol; 1998; 16(2):135-40. PubMed ID: 9536388
[TBL] [Abstract][Full Text] [Related]
28. [Significance of nailfold capilloscopy in patient with Raynaud's phenomenon].
Lee SS; Ho HH; Lu ST; Luo SF
Changgeng Yi Xue Za Zhi; 1987 Dec; 10(4):332-8. PubMed ID: 3455303
[No Abstract] [Full Text] [Related]
29. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
Curr Opin Rheumatol; 1997 Nov; 9(6):B199-206. PubMed ID: 9375289
[No Abstract] [Full Text] [Related]
30. Raynaud's Phenomenon.
Wigley FM; Flavahan NA
N Engl J Med; 2016 Aug; 375(6):556-65. PubMed ID: 27509103
[No Abstract] [Full Text] [Related]
31. [Capillaroscopy and vascular acrosyndromes].
Planchon B; Pistorius MA
J Mal Vasc; 1999 Dec; 24(5):357-62. PubMed ID: 10642647
[TBL] [Abstract][Full Text] [Related]
32. [Raynaud's phenomenon and sclerodermia].
Ezquerra Gadea J; López Larrayoz I; García Cores F; García Muñoz M
Aten Primaria; 2003 Jun; 32(1):60. PubMed ID: 12812693
[No Abstract] [Full Text] [Related]
33. Alteration of microcirculation is a hallmark of very early systemic sclerosis patients: a laser speckle contrast analysis.
Della Rossa A; Cazzato M; d'Ascanio A; Tavoni A; Bencivelli W; Pepe P; Mosca M; Baldini C; Rossi M; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):109-14. PubMed ID: 23073231
[TBL] [Abstract][Full Text] [Related]
34. Cold extremities: investigation and management of Raynaud's phenomenon.
Farrington NK; Sutej PG
J South Orthop Assoc; 1996; 5(1):37-45. PubMed ID: 8673588
[TBL] [Abstract][Full Text] [Related]
35. A growing need for capillaroscopy in rheumatology.
De Angelis R; Grassi W; Cutolo M
Arthritis Rheum; 2009 Mar; 61(3):405-10. PubMed ID: 19248132
[No Abstract] [Full Text] [Related]
36. Prognostic significance of Raynaud's phenomenon and other clinical characteristics of systemic scleroderma. A study of 271 cases.
FARMER RG; GIFFORD RW; HINES EA
Circulation; 1960 Jun; 21():1088-95. PubMed ID: 13821594
[No Abstract] [Full Text] [Related]
37. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
Wigley FM
Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460
[TBL] [Abstract][Full Text] [Related]
38. [Raynaud's syndrome and scleroderma. I. Scleroderma-like changes in Raynaud's syndrome and their differentiation from scleroderma].
JABLONSKA S; LUKASIAK B; BUBNOW B
Pol Tyg Lek (Wars); 1957 Sep; 12(39):1481-6. PubMed ID: 13505250
[No Abstract] [Full Text] [Related]
39. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
[TBL] [Abstract][Full Text] [Related]
40. Diffuse scleroderma and Raynaud's disease.
JABLONSKA S; BUBNOW B; SZCZEPANSKI A
Br J Dermatol; 1962 May; 74():174-82. PubMed ID: 14450537
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
